Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Andre

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2024
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patientsJulie R Brahmer, Georgina V Long, Omid Hamid, et al.
The New England Journal of Medicine|November 27, 2024
Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal CancerThierry Andre, Elena Elez, Eric Van Cutsem, et al.
Journal of the National Cancer Institute|August 18, 2021
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT DatabaseZhaohui Jin, Jesse G Dixon, Jack M Fiskum, et al.
Journal for Immunotherapy of Cancer|February 10, 2025
Sex and outcomes of patients with microsatellite instability-high and <i>BRAF</i> V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitorsVincenzo Nasca, Joseph Zhao, Javier Ros, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2024
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysisRomain Cohen, Morteza Raeisi, Benoist Chibaudel, et al.
Cancer Discovery|April 10, 2022
PD-1 Blockade in Solid Tumors with Defects in Polymerase EpsilonBenoit Rousseau, Ivan Bieche, Eric Pasmant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset, Josef Thaler, Richard Greil, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2024
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patientsJulie R Brahmer, Georgina V Long, Omid Hamid, et al.
The New England Journal of Medicine|November 27, 2024
Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal CancerThierry Andre, Elena Elez, Eric Van Cutsem, et al.
Journal of the National Cancer Institute|August 18, 2021
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT DatabaseZhaohui Jin, Jesse G Dixon, Jack M Fiskum, et al.
Journal for Immunotherapy of Cancer|February 10, 2025
Sex and outcomes of patients with microsatellite instability-high and <i>BRAF</i> V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitorsVincenzo Nasca, Joseph Zhao, Javier Ros, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2024
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysisRomain Cohen, Morteza Raeisi, Benoist Chibaudel, et al.
Cancer Discovery|April 10, 2022
PD-1 Blockade in Solid Tumors with Defects in Polymerase EpsilonBenoit Rousseau, Ivan Bieche, Eric Pasmant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset, Josef Thaler, Richard Greil, et al.
Pageof 6